Literature DB >> 23652603

Isolation and characterization of spliceostatin B, a new analogue of FR901464, from Pseudomonas sp. No. 2663.

Xiangyang Liu1, Sreya Biswas, Gong-Li Tang, Yi-Qiang Cheng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23652603      PMCID： PMC4067007          DOI： 10.1038/ja.2013.38

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  10 in total

1.  Structure-activity relationship for FR901464: a versatile method for the conversion and preparation of biologically active biotinylated probes.

Authors:  Hajime Motoyoshi; Masato Horigome; Ken Ishigami; Tatsuhiko Yoshida; Sueharu Horinouchi; Minoru Yoshida; Hidenori Watanabe; Takeshi Kitahara
Journal:  Biosci Biotechnol Biochem       Date:  2004-10       Impact factor: 2.043

2.  Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.

Authors:  Daisuke Kaida; Hajime Motoyoshi; Etsu Tashiro; Takayuki Nojima; Masatoshi Hagiwara; Ken Ishigami; Hidenori Watanabe; Takeshi Kitahara; Tatsuhiko Yoshida; Hidenori Nakajima; Tokio Tani; Sueharu Horinouchi; Minoru Yoshida
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

3.  Total syntheses, fragmentation studies, and antitumor/antiproliferative activities of FR901464 and its low picomolar analogue.

Authors:  Brian J Albert; Ananthapadmanabhan Sivaramakrishnan; Tadaatsu Naka; Nancy L Czaicki; Kazunori Koide
Journal:  J Am Chem Soc       Date:  2007-02-06       Impact factor: 15.419

4.  New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action.

Authors:  H Nakajima; Y Hori; H Terano; M Okuhara; T Manda; S Matsumoto; K Shimomura
Journal:  J Antibiot (Tokyo)       Date:  1996-12       Impact factor: 2.649

5.  Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464.

Authors:  Sami Osman; Brian J Albert; Yanping Wang; Miaosheng Li; Nancy L Czaicki; Kazunori Koide
Journal:  Chemistry       Date:  2010-11-19       Impact factor: 5.236

6.  New antitumor substances, FR901463, FR901464 and FR901465. III. Structures of FR901463, FR901464 and FR901465.

Authors:  H Nakajima; S Takase; H Terano; H Tanaka
Journal:  J Antibiot (Tokyo)       Date:  1997-01       Impact factor: 2.649

7.  New antitumor substances, FR901463, FR901464 and FR901465. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

Authors:  H Nakajima; B Sato; T Fujita; S Takase; H Terano; M Okuhara
Journal:  J Antibiot (Tokyo)       Date:  1996-12       Impact factor: 2.649

8.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

9.  TLC fractionation and visualization of selected phenolic compounds applied as drugs.

Authors:  W Wardas; I Lipska; K Bober
Journal:  Acta Pol Pharm       Date:  2000 Jan-Feb       Impact factor: 0.330

10.  Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43.

Authors:  Xiangyang Liu; Sreya Biswas; Michael G Berg; Christopher M Antapli; Feng Xie; Qi Wang; Man-Cheng Tang; Gong-Li Tang; Lixin Zhang; Gideon Dreyfuss; Yi-Qiang Cheng
Journal:  J Nat Prod       Date:  2013-03-21       Impact factor: 4.050
  10 in total
  6 in total

1.  Spliceostatin hemiketal biosynthesis in Burkholderia spp. is catalyzed by an iron/α-ketoglutarate-dependent dioxygenase.

Authors:  Alessandra S Eustáquio; Jeffrey E Janso; Anokha S Ratnayake; Christopher J O'Donnell; Frank E Koehn
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-05       Impact factor: 11.205

2.  Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs.

Authors:  Kerstin A Effenberger; David D Anderson; Walter M Bray; Beth E Prichard; Nianchun Ma; Matthew S Adams; Arun K Ghosh; Melissa S Jurica
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

Review 3.  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.

Authors:  Arun K Ghosh; Jennifer L Mishevich; Melissa S Jurica
Journal:  J Nat Prod       Date:  2021-05-11       Impact factor: 4.803

4.  Improved production of cytotoxic thailanstatins A and D through metabolic engineering of Burkholderia thailandensis MSMB43 and pilot scale fermentation.

Authors:  Xiangyang Liu; Hui Zhu; Sreya Biswas; Yi-Qiang Cheng
Journal:  Synth Syst Biotechnol       Date:  2016-04-01

Review 5.  Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment.

Authors:  Nancy Martínez-Montiel; Nora Hilda Rosas-Murrieta; Mónica Martínez-Montiel; Mayra Patricia Gaspariano-Cholula; Rebeca D Martínez-Contreras
Journal:  Biomed Res Int       Date:  2016-08-16       Impact factor: 3.411

Review 6.  Generate a bioactive natural product library by mining bacterial cytochrome P450 patterns.

Authors:  Xiangyang Liu
Journal:  Synth Syst Biotechnol       Date:  2016-02-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.